SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013349
Filing Date
2020-11-09
Accepted
2020-11-09 16:07:56
Documents
99
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20200930x10q.htm   iXBRL 10-Q 4510128
2 EX-10.1 fbio-20200930xex10d1.htm EX-10.1 840595
3 EX-31.1 fbio-20200930xex31d1.htm EX-31.1 13871
4 EX-31.2 fbio-20200930xex31d2.htm EX-31.2 14573
5 EX-32.1 fbio-20200930xex32d1.htm EX-32.1 8239
6 EX-32.2 fbio-20200930xex32d2.htm EX-32.2 8194
  Complete submission text file 0001558370-20-013349.txt   17638583

Data Files

Seq Description Document Type Size
7 EX-101.SCH fbio-20200930.xsd EX-101.SCH 117850
8 EX-101.CAL fbio-20200930_cal.xml EX-101.CAL 94302
9 EX-101.DEF fbio-20200930_def.xml EX-101.DEF 441883
10 EX-101.LAB fbio-20200930_lab.xml EX-101.LAB 738048
11 EX-101.PRE fbio-20200930_pre.xml EX-101.PRE 672131
12 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20200930x10q_htm.xml XML 3650428
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 201297734
SIC: 2834 Pharmaceutical Preparations